Search results
Author(s):
William Herrington
Added:
1 year ago
Long-term cardio-renal outcomes investigating empagliflozin (Boehringer Ingelheim) on kidney disease progression (KDP) or cardiovascular death in patients with pre-existing chronic kidney disease.In this short interview, Prof William Herrington (Nuffield Department of Population Health, University of Oxford, Oxford, UK) discusses the findings from EMPA-KIDNEY (NCT03594110).EMPA-KIDNEY is an…
View more
Updates on Chronic Coronary Syndrome
Author(s):
Filippo Gurgoglione
,
Giampaolo Niccoli
Added:
1 year ago
Editorial
Author(s):
Inés Martínez-Salgado
,
Manuel Sánchez
,
Diego De la Eranueva Calvo
,
et al
Added:
3 weeks ago
Author(s):
Diego Manuel de la Eranueva
,
Ignacio Quevedo
,
Adela Castro Garcia
,
et al
Added:
3 weeks ago
Gabriele Gasparini
Job title: Interventional Cardiologist
Author
Max W Maffey
Author
Ziad A Ali
Research Area(s) / Expertise:
Author
Pablo Lamelas
Research Area(s) / Expertise:
Job title: Interventional Cardiologist
Author
Sanjog Kalra
Job title: Interventional Cardiologist
Author
Author(s):
Purvi Parwani
Added:
1 month ago
Dr Purvi Parwani (Loma Linda University Health, US) recaps the standout science from Day 2 of ACC 2026, a day defined by a central theme: challenging long-held assumptions in cardiology. Her summary focuses on what these updates mean for day-to-day clinical practice, from prevention strategies to interventional decision-making.Prevention and Risk ReductionVESALIUS-CV: Showed a 25% reduction in…
View more